Deconstructing the Placebo Effect and Finding the Meaning Response
- Daniel E. Moerman, PhD; and
- Wayne B. Jonas, MD
-
From University of Michigan, Dearborn, Michigan; and Samueli Institute and Uniformed Services University of the Health Sciences,
Bethesda, Maryland.
-
Figure. In all cases, ulcers and ulcer healing were diagnosed endoscopically. Most studies lasted 4 weeks; a few were a bit
shorter or longer. Sample sizes ranged from 12 to 210 participants (mean, 58). The quality of these studies was generally
good for the era in which they were conducted (mostly between 1976 and 1986), although probably not fully adequate by contemporary
standards. This analysis differs from the ordinary, in which placebo and active treatments are combined in an odds ratio,
relative risk, or risk difference. The point of this analysis is not, however, to determine whether antisecretory medication
is effective; clearly it is. The issue is the relationship between the pharmacologic and the meaningful dimensions of treatment.
(A detailed account of these studies is available elsewhere .). Data from 83 studies of the use of cimetidine or ranitidine for duodenal ulcer disease.[42]
- Copyright ©2004 by the American College of Physicians
-
Ann Intern Med
March 19, 2002
vol. 136
no. 6
471-476